Static Wrinkle Reduction
Combined treatment method to reduce static wrinkles visible at rest.
Treatment Information
Duration
45-60 minutes
Body Location
Forehead, glabella, crow’s feet, masseter or selected facial muscles after assessment
Preparation
Avoid alcohol and blood thinners 24 hours before. Moisturized skin easier to treat.
Follow-up Care
Swelling and bruising may persist 1-2 weeks. SPF 50+ sunscreen recommended.
How It Is Performed
Dermal fillers fill wrinkles and laser/light improves skin quality.
Frequently Asked Questions
Dynamic: visible during expression. Static: always visible. Static needs fillers or laser.
Yes, Botox and fillers can be combined for optimal results.
Varies by wrinkle depth. Mild 1-2, deep 3-4 sessions may be needed.
Pregnancy, nursing, severe skin infections, coagulation disorders are contraindications.
Bruising, swelling, mild pain persist 1-2 weeks. Rare granulomas; but reversible.
Yes, experienced doctor fills wrinkles while preserving facial movement. Subtle, not exaggerated.
Immediately, but may have bruising. Makeup recommended. 1-2 days rest is good.
Static Wrinkle Reduction — Related Medical Terms
Deep-dive in our glossary: definition, indications, side effects and FAQs.
Forehead Botox
Forehead botox; It is an FDA-approved non-invasive aesthetic procedure that blocks muscle contraction and reduces dynamic lines by injecting Botulinum toxin type A into the frontal muscle (musculus frontalis) and surrounding muscles in order to treat horizontal forehead lines and wrinkles.
Crow's Feet Botox
Crow's feet botox; It is Botulinum toxin type A injection applied to the orbicularis oculi muscle to treat dynamic lines that open out from the corners of the eyes (lateral canthal lines). It is applied in a dose of 6-9 units with a standard 3-point injection pattern and reduces laughing lines for 3-6 months.
microbotox
Microbotox (other names: MesoBotox, Dermal Botox) is the intradermal injection of diluted Botulinum toxin type A into the superficial dermal layer in micro-doses of 0.01-0.03 mL; It aims to improve skin quality, pore tightness, sebum production and sweat production without affecting the facial muscles.
Baby Botox
Baby Botox is an intramuscular injection treatment that aims to prevent wrinkles in young patients between the ages of 20-35, with a dose reduced to 30-50% of the classical botox, and gives maximum priority to preserving natural facial expressions.
frontalis
The frontal belly of the occipitofrontalis muscle, which pulls the forehead skin and eyebrows upward; Bilateral facial muscle, which is the primary cause of forehead lines and the main target of forehead botox.
Corrugator Supercilii
The glabella muscle is the pyramidal muscle located behind the medial superciliary (above the eyebrow) of the forehead area; The main muscle that works bilaterally and pulls the eyebrows medially and downwards, forming the pionels and glabellar "11 lines"; The primary goal of Botox treatment.
procerus
The small pyramidal muscular structure located on the root of the nose is the facial expression muscle that pulls the eyebrows medially and creates horizontal "rabbit lines" in the glabella region; Glabellar complex is the primary target of Botox applications.
retinol
Retinol is the pre-vitamin form of Vitamin A1 (C20H30O), which is metabolized into retinal and retinoic acid in the skin and provides increased cellular turnover, collagen synthesis stimulation, melanin inhibition and anti-photoaging effects through nuclear receptors, and is the gold standard anti-aging active ingredient of the cosmetic industry.
Daxxify (Daxibotulinumtoxin-A)
Daxxify; Botulinum toxin type A product, developed by Revance Therapeutics, containing a peptide stimulator (RTP-004) and approved by the FDA for cosmetic indication in 2022, used in the treatment of glabellar wrinkles; It is a longer-acting alternative to Botox, with an effect duration of up to 6 months.
Jeuveau (Prabotulinumtoxin-A)
Jeuveau; Evolus Inc. It is a botulinum toxin type A neurotoxin injection treatment, containing prabotulinumtoxin-A, produced by Daewoong Pharmaceutical (South Korea), marketed by Daewoong Pharmaceutical (South Korea), approved by the FDA in 2019 primarily for cosmetic indication (glabellar lines), has a dose equivalent to Botox, has a rapid onset of effect (2-3 days) and is positioned with an economical price.
Related Services
Plan an Assessment
Contact Dr. Hamza Gemici’s clinic for individualized assessment and candidacy planning.